The Latin America, Middle East and Africa Prosthetics and Orthotics Market is expected to witness market growth of 5.6% CAGR during the forecast period (2019-2025).
The emergence of new treatments in Middle Eastern countries for metastatic osteosarcoma treatment will further accelerate market growth. For example, clinical trials of drugs focused on immunotherapy and targeted drug therapy are likely to be a preferred choice in the near future, leading to fewer side effects. The immune therapy drug called immune checkpoint inhibitors can identify and destroy cancer cells that produce better results for other types of cancer, and tests have also shown that it is also effective for treating osteosarcoma. In addition, engineered monoclonal antibodies are used to curb cancer growth by hampering the formation of new blood vessels or by targeting mTOR protein to kill tumor cells.
With the progressive healthcare reforms of today, the capacity of the O&SP physician to measure the quality of healthcare delivery and cost-effectiveness of treatment is essential for the future success of the clinical practice. In the manufacturing sector, the emergence of total quality management has developed concepts of quality control procedures. Today, managed care, government, and other businesses assess and use outcome measures as the primary mode of quality assessment of the delivery of healthcare.
Based on Type, the market is segmented into Orthotics and Prosthetics. Based on Orthotics Category, the market is segmented into Upper limb, Lower limb and Spinal. Based on Prosthetics Category, the market is segmented into Upper extremity, Lower extremity, Liners, Sockets and Modular components. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Ossur Hf., Zimmer Biomet Holdings, Inc., Blatchford Limited, Fillauer LLC (Fillauer Companies, Inc.), Otto Bock Healthcare GmbH (Otto Bock Holding GmbH & Co. KG), WillowWood Global LLC, Ultraflex Systems, Inc., Johnson and Johnson, Stryker Corporation, and Smith & Nephew PLC.
Scope of the Study
Market Segmentation:
By Type
By Category
By Category
By Country
Companies Profiled
Unique Offerings from the Publisher
The emergence of new treatments in Middle Eastern countries for metastatic osteosarcoma treatment will further accelerate market growth. For example, clinical trials of drugs focused on immunotherapy and targeted drug therapy are likely to be a preferred choice in the near future, leading to fewer side effects. The immune therapy drug called immune checkpoint inhibitors can identify and destroy cancer cells that produce better results for other types of cancer, and tests have also shown that it is also effective for treating osteosarcoma. In addition, engineered monoclonal antibodies are used to curb cancer growth by hampering the formation of new blood vessels or by targeting mTOR protein to kill tumor cells.
With the progressive healthcare reforms of today, the capacity of the O&SP physician to measure the quality of healthcare delivery and cost-effectiveness of treatment is essential for the future success of the clinical practice. In the manufacturing sector, the emergence of total quality management has developed concepts of quality control procedures. Today, managed care, government, and other businesses assess and use outcome measures as the primary mode of quality assessment of the delivery of healthcare.
Based on Type, the market is segmented into Orthotics and Prosthetics. Based on Orthotics Category, the market is segmented into Upper limb, Lower limb and Spinal. Based on Prosthetics Category, the market is segmented into Upper extremity, Lower extremity, Liners, Sockets and Modular components. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Ossur Hf., Zimmer Biomet Holdings, Inc., Blatchford Limited, Fillauer LLC (Fillauer Companies, Inc.), Otto Bock Healthcare GmbH (Otto Bock Holding GmbH & Co. KG), WillowWood Global LLC, Ultraflex Systems, Inc., Johnson and Johnson, Stryker Corporation, and Smith & Nephew PLC.
Scope of the Study
Market Segmentation:
By Type
- Orthotics
- Prosthetics
By Category
- Upper limb
- Lower limb
- Spinal
By Category
- Upper extremity
- Lower extremity
- Liners
- Sockets
- Modular components
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Ossur Hf.
- Zimmer Biomet Holdings, Inc.
- Blatchford Limited
- Fillauer LLC (Fillauer Companies, Inc.)
- Otto Bock Healthcare GmbH (Otto Bock Holding GmbH & Co. KG)
- WillowWood Global LLC
- Ultraflex Systems, Inc.
- Johnson and Johnson
- Stryker Corporation
- Smith & Nephew PLC
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Prosthetics and Orthotics Market by Type
Chapter 5. LAMEA Prosthetics and Orthotics Market by Country
Chapter 6. Company Profiles
Companies Mentioned
- Ossur Hf.
- Zimmer Biomet Holdings, Inc.
- Blatchford Limited
- Fillauer LLC (Fillauer Companies, Inc.)
- Otto Bock Healthcare GmbH (Otto Bock Holding GmbH & Co. KG)
- WillowWood Global LLC
- Ultraflex Systems, Inc.
- Johnson and Johnson
- Stryker Corporation
- Smith & Nephew PLC
Methodology
LOADING...
